High-throughput sequencing approach for the identification of lncRNA biomarkers in hepatocellular carcinoma and revealing the effect of ZFAS1/miR-150-5p on hepatocellular carcinoma progression
Peng Zhu(Ningbo University), Huiying Liu(Second Affiliated Hospital of Zhejiang University), Ze‐Ya Pan(Second Military Medical University), Zongyan Wang, Yongyan Pei(Guangdong Pharmaceutical University), Jinzhong Chen(Affiliated Hospital of Youjiang Medical University for Nationalities), Yun Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Lei Liu(Aerospace Research Institute of Materials and Processing Technology), Jian Yu, Fangming Gu, Fuchen Liu(Second Military Medical University), Jian Huang, Wenbin Ding, Jinrong Qiu(Jiangsu Province Hospital), Shengxian Yuan(Second Military Medical University)
Cited by 19
Related Papers
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
|Journal of Hepatology|2014|335
microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
|British Journal of Cancer|2010|252
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial
|The Lancet. Gastroenterology & hepatology|2019|230
Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma
|Annals of Surgery|2014|229